6FOG | pdb_00006fog

X-ray structure of homo sapiens Fumarylacetoacetate hydrolase domain containing protein 1 (FAHD1) in complex with inhibitor oxalate at 1.94A resolution.

External Resource: Annotation

Domain Annotation: SCOP/SCOPe Classification
Domain Annotation: SCOP2 Classification
Domain Annotation: ECOD Classification
Domain Annotation: CATH
Protein Family Annotation
Gene Ontology: Gene Product Annotation
InterPro: Protein Family Classification
Pharos: Disease Associations

Domain Annotation: SCOP/SCOPe Classification SCOP-e Database Homepage

Chains	Domain Info	Class	Fold	Superfamily	Family	Domain	Species	Provenance Source (Version)
H [auth E]	d6foge_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
G [auth H]	d6fogh_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
F [auth C]	d6fogc_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
E [auth B]	d6fogb_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
D	d6fogd_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
C [auth F]	d6fogf_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
B [auth G]	d6fogg_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)
A	d6foga_	Alpha and beta proteins (a+b)	FAH	FAH	FAH	automated matches	Human (Homo sapiens ) [TaxId: 9606 ],	SCOPe (2.08)

Domain Annotation: SCOP2 Classification SCOP2 Database Homepage

Chains	Type	Family Name	Domain Identifier	Family Identifier	Provenance Source (Version)
H [auth E]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
G [auth H]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
F [auth C]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
E [auth B]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
D	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
C [auth F]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
B [auth G]	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)
A	SCOP2B Superfamily	FAH	8042321	3001446	SCOP2B (2022-06-29)

Domain Annotation: ECOD Classification ECOD Database Homepage

Chains	Family Name	Domain Identifier	Architecture	Possible Homology	Homology	Topology	Family	Provenance Source (Version)
H [auth E]	FAA_hydrolase	e6fogE1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
G [auth H]	FAA_hydrolase	e6fogH1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
F [auth C]	FAA_hydrolase	e6fogC1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
E [auth B]	FAA_hydrolase	e6fogB1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
D	FAA_hydrolase	e6fogD1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
C [auth F]	FAA_hydrolase	e6fogF1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
B [auth G]	FAA_hydrolase	e6fogG1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)
A	FAA_hydrolase	e6fogA1	A: beta sandwiches	X: Immunoglobulin-like beta-sandwich	H: FAH (From Topology)	T: FAH	F: FAA_hydrolase	ECOD (1.6)

Domain Annotation: CATH CATH Database Homepage

Chain	Domain	Class	Architecture	Topology	Homology	Provenance Source (Version)
H [auth E]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
G [auth H]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
F [auth C]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
E [auth B]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
D	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
C [auth F]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
B [auth G]	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)
A	3.90.850.10	Alpha Beta	Alpha-Beta Complex	Fumarylacetoacetate hydrolase	domain 2	CATH (4.3.0)

Protein Family Annotation Pfam Database Homepage

Chains	Accession	Name	Description	Comments	Source
A, B [auth G], C [auth F], D, E [auth B], A, B [auth G], C [auth F], D, E [auth B], F [auth C], G [auth H], H [auth E]	PF01557	Fumarylacetoacetate (FAA) hydrolase C-terminal (FAA_hydrolase)	Fumarylacetoacetate (FAA) hydrolase C-terminal	This entry consists of fumarylacetoacetate (FAA) hydrolase, or fumarylacetoacetate hydrolase (FAH) and it also includes HHDD isomerase/OPET decarboxylase from E. coli strain W. FAA is the last enzyme in the tyrosine catabolic pathway, it hydroly ...	This entry consists of fumarylacetoacetate (FAA) hydrolase, or fumarylacetoacetate hydrolase (FAH) and it also includes HHDD isomerase/OPET decarboxylase from E. coli strain W. FAA is the last enzyme in the tyrosine catabolic pathway, it hydrolyses fumarylacetoacetate into fumarate and acetoacetate which then join the citric acid cycle [1]. Mutations in FAA cause type I tyrosinemia in humans this is an inherited disorder mainly affecting the liver leading to liver cirrhosis, hepatocellular carcinoma, renal tubular damages and neurologic crises amongst other symptoms [1]. The enzymatic defect causes the toxic accumulation of phenylalanine/tyrosine catabolites [3]. The E. coli W enzyme HHDD isomerase/OPET decarboxylase contains two copies of this domain and functions in fourth and fifth steps of the homoprotocatechuate pathway; here it decarboxylates OPET to HHDD and isomerises this to OHED. The final products of this pathway are pyruvic acid and succinic semialdehyde. This family also includes various hydratases and 4-oxalocrotonate decarboxylases which are involved in the bacterial meta-cleavage pathways for degradation of aromatic compounds. 2-hydroxypentadienoic acid hydratase encoded by mhpD in E. coli Swiss:P77608 is involved in the phenylpropionic acid pathway of E. coli and catalyses the conversion of 2-hydroxy pentadienoate to 4-hydroxy-2-keto-pentanoate and uses a Mn2+ co-factor [5]. OHED hydratase encoded by hpcG in E. coli Swiss:P42270 is involved in the homoprotocatechuic acid (HPC) catabolism [6]. XylI in P. putida Swiss:P49155 is a 4-Oxalocrotonate decarboxylase [7].	Domain

Gene Ontology: Gene Product Annotation Gene Ontology Database Homepage

Chains	Polymer	Molecular Function	Biological Process	Cellular Component
A, B [auth G], C [auth F], D, E [auth B], A, B [auth G], C [auth F], D, E [auth B], F [auth C], G [auth H], H [auth E]	Acylpyruvase FAHD1, mitochondrial	intramolecular oxidoreductase activity, interconverting keto- and enol-groups isomerase activity intramolecular oxidoreductase activity oxaloacetate tautomerase activity catalytic activity hydrolase activity, acting on acid carbon-carbon bonds hydrolase activity acetylpyruvate hydrolase activity hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances fumarylpyruvate hydrolase activity oxaloacetate decarboxylase activity carboxy-lyase activity lyase activity carbon-carbon lyase activity intramolecular oxidoreductase activity, interconverting keto- and enol-groups isomerase activity intramolecular oxidoreductase activity oxaloacetate tautomerase activity catalytic activity hydrolase activity, acting on acid carbon-carbon bonds hydrolase activity acetylpyruvate hydrolase activity hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances fumarylpyruvate hydrolase activity oxaloacetate decarboxylase activity carboxy-lyase activity lyase activity carbon-carbon lyase activity acylpyruvate hydrolase activity cation binding ion binding binding metal ion binding small molecule binding	pyruvate metabolic process oxoacid metabolic process carboxylic acid metabolic process small molecule metabolic process metabolic process cellular process monocarboxylic acid metabolic process organic acid metabolic process dicarboxylic acid metabolic process oxaloacetate metabolic process	membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle cytosol nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen membrane-bounded organelle intracellular organelle cellular anatomical structure intracellular anatomical structure mitochondrion organelle cytoplasm intracellular membrane-bounded organelle cytosol nucleus membrane-enclosed lumen intracellular organelle lumen nucleoplasm organelle lumen nuclear lumen mitochondrial matrix

InterPro: Protein Family Classification InterPro Database Homepage

Chains	Accession	Name	Type
A, B [auth G], C [auth F], D, E [auth B], A, B [auth G], C [auth F], D, E [auth B], F [auth C], G [auth H], H [auth E]	IPR036663	Fumarylacetoacetase-like, C-terminal domain superfamily	Homologous Superfamily
A, B [auth G], C [auth F], D, E [auth B], A, B [auth G], C [auth F], D, E [auth B], F [auth C], G [auth H], H [auth E]	IPR011234	Fumarylacetoacetase-like, C-terminal	Domain

Pharos: Disease Associations Pharos Homepage Annotation

Chains	Drug Target	Associated Disease
A, B [auth G], C [auth F], D, E [auth B], A, B [auth G], C [auth F], D, E [auth B], F [auth C], G [auth H], H [auth E]	Pharos: Q6P587	Liver Cirrhosis, Experimental atypical teratoid rhabdoid tumor malignant glioma pancreatic ductal adenocarcinoma large cell medulloblastoma medulloblastoma ovarian cancer

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.